Company name Amazon.com, Inc.
Stock ticker AMZN
Live stock price [stckqut]AMZN[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $2475.45
Target stock price (averages with growth) $3644.31
Target stock price (averages with no growth) $2475.45
Target stock price (manual assumptions) $2486.50

 

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/amzn

Amazon.com, Inc., incorporated on May 28, 1996, offers a range of products and services through its Web sites. The Company operates through three segments: North America, International and Amazon Web Services (AWS). The Company’s products include merchandise and content that it purchases for resale from vendors and those offered by third-party sellers. It also manufactures and sells electronic devices. The Company, through its subsidiary, Whole Foods Market, Inc., offers healthy and organic food and staples across its stores. The Company also offers a range of products like whole trade bananas, organic avocados, organic large brown eggs, organic responsibly-farmed salmon and tilapia, organic baby kale and baby lettuce, animal-welfare-rated 85% lean ground beef, creamy and crunchy almond butter, organic gala and fuji apples, organic rotisserie chicken.

The Company’s Whole Foods Market healthy and private label products include 365 Everyday Value, Whole Foods Market, Whole Paws and Whole Catch available through Amazon.com, AmazonFresh, Prime Pantry and Prime Now. The Company also offers Amazon Lockers that is available in select Whole Foods Market stores. Customers can have products shipped from www.Amazon.com to their local Whole Foods Market store for pick up or send returns back to Amazon during a trip to the store.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Amazon.com, Inc. as long as the price is correct and the indicators that I describe in my book The Confident Investor are favorable. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Amazon.com, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $1602.91
  • Growth: 0.15
  • Current EPS (TTM): $6.34
  • P/E: 44
  • Future EPS Calc: $12.75
  • Future Stock Price Calc: $561.08
  • Target stock price: $348.39

[/s2If]
I hope that this makes you a Confident Investor.

Company name UnitedHealth Group Inc
Stock ticker UNH
Live stock price [stckqut]UNH[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Fair
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $270.04
Target stock price (averages with growth) $372.09
Target stock price (averages with no growth) $289.64
Target stock price (manual assumptions) $557.21

 

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/unh

UnitedHealth Group Incorporated, incorporated on July 1, 2015, is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. UnitedHealthcare provides healthcare benefits to an array of customers and markets, and includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, and UnitedHealthcare Global businesses. Optum is a health services business serving the healthcare marketplace, including payers, care providers, employers, governments, life sciences companies and consumers, through its OptumHealth, OptumInsight and OptumRx businesses.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in UnitedHealth Group Inc as long as the indicators that I describe in my book The Confident Investor are favorable. I will be adding UNH to my Watch List.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of UnitedHealth Group Inc calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $238.28
  • Growth: 0.15
  • Current EPS (TTM): $10.14
  • P/E: 44
  • Future EPS Calc: $20.39
  • Future Stock Price Calc: $897.38
  • Target stock price: $557.2

[/s2If]
I hope that this makes you a Confident Investor.

Company name Applied Materials, Inc.
Stock ticker AMAT
Live stock price [stckqut]AMAT[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $84.87
Target stock price (averages with growth) $122.05
Target stock price (averages with no growth) $82.9
Target stock price (manual assumptions) $197.28

 

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/amat

Applied Materials, Inc. (Applied), incorporated on March 18, 1987, provides manufacturing equipment, services, and software to the global semiconductor, display and related industries. The Company’s segments are Semiconductor Systems; Applied Global Services; Display and Adjacent Markets, and Corporate and Other. The Semiconductor Systems segment includes semiconductor capital equipment for etching, rapid thermal processing, deposition, chemical mechanical planarization, metrology and inspection, wafer packaging and ion implantation. Its Applied Global Services segment provides integrated solutions to optimize equipment and fab performance and productivity, including spares, upgrades, services, certain remanufactured earlier generation equipment, and factory automation software for semiconductor, display and solar products. The Display and Adjacent Markets segment includes products for manufacturing liquid crystal displays (LCDs), organic light-emitting diodes (OLEDs), upgrades and roll-to-roll Web coating systems and other display technologies for televisions, personal computers, smartphones and other consumer-oriented devices. The Corporate and Other segment includes revenues from products, as well as costs of products sold for fabricating solar photovoltaic cells and modules, and certain operating expenses.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Applied Materials, Inc. as long as the indicators that I describe in my book The Confident Investor are favorable.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Applied Materials, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $54.84
  • Growth: 0.15
  • Current EPS (TTM): $3.59
  • P/E: 44
  • Future EPS Calc: $7.22
  • Future Stock Price Calc: $317.71
  • Target stock price: $197.27

[/s2If]
I hope that this makes you a Confident Investor.

Company name Alexion Pharmaceuticals, Inc.
Stock ticker ALXN
Live stock price [stckqut]ALXN[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $154.89
Target stock price (averages with growth) $217.89
Target stock price (averages with no growth) $160.22
Target stock price (manual assumptions) $148.92

 

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/alxn

Alexion Pharmaceuticals, Inc., incorporated on January 28, 1992, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company’s products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company’s clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous).

The Company’s product, Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or atypical hemolytic uremic syndrome (aHUS). PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system. Soliris is designed to inhibit a specific aspect of the component of the immune system and treat inflammation associated with chronic disorders in various therapeutic areas, including hematology, nephrology, neurology and transplant rejection. It is a humanized monoclonal antibody that blocks terminal complement activity. It is approved for the treatment of PNH in the United States, Europe, Japan and in various other territories. It is approved for the treatment of pediatric and adult patients with aHUS in the United States, Europe, and Japan.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Alexion Pharmaceuticals, Inc. as long as the indicators that I describe in my book The Confident Investor are favorable.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Alexion Pharmaceuticals, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $119.66
  • Growth: 0.15
  • Current EPS (TTM): $2.71
  • P/E: 44
  • Future EPS Calc: $5.45
  • Future Stock Price Calc: $239.83
  • Target stock price: $148.91

[/s2If]
I hope that this makes you a Confident Investor.

Symbol Stock Price change today
REGN Regeneron Pharmaceuticals Inc 6.2444%
ALGN Align Technology, Inc. 3.1541%
ALXN Alexion Pharmaceuticals, Inc. 3.0397%
MRK Merck & Co., Inc. 2.8074%
CVCO Cavco Industries, Inc. 2.0713%
CEVA CEVA, Inc. 1.8182%
MCK McKesson Corporation 1.3242%
TMO Thermo Fisher Scientific Inc. 1.2768%
CBPO China Biologic Products Holdings, Inc. 1.2216%
GILD Gilead Sciences, Inc. 1.2085%
ABMD ABIOMED, Inc. 1.0301%
ULTA Ulta Beauty Inc 1.0101%
EW Edwards Lifesciences Corp 0.9724%
HZO MarineMax Inc 0.8584%
TNET TriNet Group Inc 0.8523%
FB Facebook Inc 0.7869%
SCHW Charles Schwab Corp 0.7797%
ILMN Illumina, Inc. 0.7585%
AYI Acuity Brands, Inc. 0.7223%
ADS Alliance Data Systems Corporation 0.6677%
LULU Lululemon Athletica inc. 0.6434%
MKTX MarketAxess Holdings Inc. 0.5474%
HSKA Heska Corp 0.4325%
ADBE Adobe Systems Incorporated 0.3027%
MIDD Middleby Corp 0.2803%
MEI Methode Electronics Inc. 0.2364%
EXR Extra Space Storage, Inc. 0.0946%
DPZ Domino’s Pizza, Inc. 0.0761%
COF Capital One Financial Corp. -0.0432%
SWKS Skyworks Solutions Inc -0.0618%
STZ Constellation Brands, Inc. -0.0726%
GWR Genesee & Wyoming Inc -0.1163%
THRM Gentherm Inc -0.1433%
GOOGL Alphabet Inc -0.1891%
ANET Arista Networks Inc -0.2877%
SUI Sun Communities Inc -0.3283%
AMZN Amazon.com, Inc. -0.3834%
BKNG Booking Holdings -0.3861%
SBUX Starbucks Corporation -0.6592%
AAPL Apple Inc. -0.763%
TMUS T-Mobile US Inc -0.8091%
BABA Alibaba Group Holding Ltd -0.8165%
NFLX Netflix, Inc. -0.9527%
IBP Installed Building Products Inc -1.0842%
CRTO Criteo SA (ADR) -1.1115%
LRCX Lam Research Corporation -1.2058%
AMAT Applied Materials, Inc. -1.2426%
MU Micron Technology, Inc. -1.5951%
GTN Gray Television, Inc. -1.6736%
LGIH LGI Homes Inc -1.9088%
CRUS Cirrus Logic, Inc. -1.9894%
NVDA NVIDIA Corporation -2.1528%
TGS Transportadora de Gas del Sur SA (ADR) -2.4873%
HDSN Hudson Technologies, Inc. -14.4951%